Sai Life Sciences IPO is set to open on December 11, 2024, and will close on December 13, 2024. The Sai Life Sciences IPO is a Book Built Issue, aiming to raise approximately ₹3,042.62 crores. This includes a fresh issue of ₹3,042.62 crores and an offer for sale of up to 38,116,934 Equity Shares. The face value of each share is ₹1.
Sai Life Sciences IPO Price band is set between ₹522 to ₹549 per share. The quota allocation is 35% for Retail investors, 50% for Qualified Institutional Buyers (QIB), and 15% for Non-Institutional Investors (HNI). Sai Life Sciences IPO is scheduled to list on BSE & NSE on December 18, 2024, with the allotment announcement on December 16, 2024.
The company reported revenue of ₹1,494.27 crores in 2024, compared to ₹1,245.11 crores in 2023. It posted a Profit of ₹82.81 crores in 2024, compared to a Profit of ₹9.99 crores in 2023. Based on the financials, IPO investors are advised to apply for the IPO for gains in the long term.
- Sai Life Sciences IPO Details
- Sai Life Sciences IPO Market Lot
- Sai Life Sciences IPO Dates
- About Sai Life Sciences
- Promoters of Sai Life Sciences
- Sai Life Sciences Financial Report
- Key Performance Indicator
- Peer Group Comparison
- Objective of the Issue
- Sai Life Sciences IPO GMP (Grey Market Premium)
- Sai Life Sciences Subscription Status
- Sai Life Sciences Allotment Status
- IPO Registrar
- IPO Lead Managers
- Sai Life Sciences Contact
- FAQs
Sai Life Sciences IPO Details
| Overview Points | Description |
|---|---|
| Company Name | Sai Life Sciences Limited |
| Industry | Pharmaceuticals |
| IPO Issue Type | Book Built Issue |
| Open Date | December 11, 2024 |
| Close Date | December 13, 2024 |
| Total Issue Size | Approx ₹3,042.62 Crores |
| Fresh Issue | Approx ₹950.00 Crores |
| Face Value | ₹1 Per Equity Share |
| Price Band | ₹522 to ₹549 Per Share |
| Listing on | BSE & NSE |
| Lot Size | 27 Shares Per Lot |
| Offer for Sale | Approx 38,116,934 Equity Shares |
| Shares Offered to Retail | 35% |
| Shares Offered to QIB | 50% |
| Shares Offered to HNI | 15% |
Sai Life Sciences IPO Market Lot
Sai Life Sciences IPO has a minimum lot size of 27 shares, with an amount of ₹14,823.
| Application | Lot Size | Shares | Amount |
|---|---|---|---|
| Retail Minimum | 1 | 27 | ₹14,823 |
| Retail Maximum | 13 | 351 | ₹192,699 |
| S-HNI Minimum | 14 | 378 | ₹207,522 |
| B-HNI Minimum | 68 | 1,836 | ₹1,007,964 |
Sai Life Sciences IPO Dates
Sai Life Sciences IPO opens on December 11, 2024, and closes on December 13, 2024. The allotment will be announced on December 16, 2024, and the IPO will be listed on December 18, 2024.
| Event | Date |
|---|---|
| IPO Open Date | December 11, 2024 |
| IPO Close Date | December 13, 2024 |
| Basis of Allotment | December 16, 2024 |
| Refunds | December 17, 2024 |
| Credit to Demat Account | December 17, 2024 |
| IPO Listing Date | December 18, 2024 |
About Sai Life Sciences
Founded in January 1999, Sai Life Science Limited is a leading Contract Research, Development, and Manufacturing Organization (CRDMO) that partners with innovative pharmaceutical and biotech companies to advance drug discovery, development, and manufacturing of small-molecule new chemical entities (NCEs). Leveraging its deep scientific expertise, the company addresses critical healthcare challenges and aspires to develop groundbreaking medicines for currently incurable conditions, shaping the future of healthcare. Sai Life Sciences customizes its services to meet the unique needs of diverse clients, ranging from small enterprises to global pharmaceutical giants, showcasing adaptability and resilience.
With strong growth in the CRDMO sector, the company has achieved significant revenue and EBITDA CAGRs from FY 2022 to FY 2024, outpacing competitors. Over its 24-year journey, it has successfully delivered a wide range of NCE development programs for clients, emphasizing quality, affordability, and responsiveness. These three pillars remain the foundation of Sai Life Science’s exceptional value to its partners.
Promoters of Sai Life Sciences
- MR. Kanumuri Ranga Raju
- MR. Krishnam Raju Kanumuri
- MRS. Kanumuri Mytrey
- Sai Quest Syn Private Limited
- Sunflower Partners
- Lily Partners
- Marigold Partners
- Tulip Partners
Sai Life Sciences Financial Report
| Period Ended | 30 Sep 2024 | 31 Mar 2024 | 31 Mar 2023 | 31 Mar 2022 |
|---|---|---|---|---|
| Assets | 2,476.78 | 2,275.14 | 2,186.65 | 2,164.23 |
| Revenue | 693.35 | 1,494.27 | 1,245.11 | 897.74 |
| Profit After Tax | 28.01 | 82.81 | 9.99 | 6.23 |
| Net Worth | 1,044.75 | 974.34 | 887.29 | 877.76 |
| Reserves and Surplus | 1,025.44 | 953.99 | 867.43 | 859.17 |
| Total Borrowing | 764.49 | 710.16 | 699.23 | 751.32 |
| Amount in ₹ Crores | ||||
Key Performance Indicator
| KPI | Values |
|---|---|
| ROE | 8.49% |
| ROCE | 10.26% |
| EBITDA Margin | 20.48% |
| PAT Margin | 5.65% |
| Debt to equity ratio | 0.75 |
| Earning Per Share (EPS) | ₹4.57 (Basic) |
| Price/Earning P/E Ratio | N/A |
| Return on Net Worth (RoNW) | 8.50% |
| Net Asset Value (NAV) | ₹53.83 |
Peer Group Comparison
| Company | EPS | PE Ratio | RoNW % | NAV | Income |
|---|---|---|---|---|---|
| Divi’s Laboratories Limited | 60.27 | 103.04 | 11.79% | 511.21 | 7,845.00 Cr. |
| Suven Pharmaceuticals Limited | 11.80 | 109.37 | 14.64% | 94.04 | 1,051.35 Cr. |
| Syngene International Limited | 12.71 | 73.59 | 11.98% | 105.91 | 3,488.60 Cr. |
Objective of the Issue
- The proceeds will be utilized for the repayment or prepayment of certain outstanding borrowings and for general corporate purposes.
Sai Life Sciences IPO GMP (Grey Market Premium)
To check real-time Grey Market Premium (GMP on IPO) of Sai Life Sciences, please visit the IPO GMP page.
Sai Life Sciences Subscription Status
This IPO subscription kicks off on December 11, 2024! Meanwhile, if you’re looking to stay updated with the latest subscription figures, head over to our IPO Subscription section for real-time data on all ongoing IPOs. Moreover, don’t miss out on the action—track the progress as it happens!
Sai Life Sciences Allotment Status
To check the Sai Life Sciences IPO allotment status, visit the IPO registrar website Kfin Tech or go to the IPO Allotment page.
IPO Registrar
KFIN TECHNOLOGIES LIMITED
Selenium Tower – B, Plot 31 & 32, Gachibowli,
Financial District, Nanakramguda, Serilingampally,
Hyderabad – 500 032, Telangana
Tel: +91 40 6716 2222
E-mail: sailifesciences.ipo@kfintech.com
Website: www.kfintech.com
IPO Lead Managers
IIFL SECURITIES LIMITED
24th Floor, One Lodha Place, Senapati Bapat Marg,
Lower Parel (West) Mumbai 400 013 Maharashtra
Phone: +91 22 4646 47283
Email: unicommerce.ipo@iiflcap.com
Website: www.iiflcap.com
Sai Life Sciences Contact
SAI LIFE SCIENCES LIMITED
L4- 01 & 02, SLN Terminus Survey,
Survey no. 133, Gachibowli Miyapur Road,
Gachibowli, Hyderabad 500 032, Telangana
Phone: +91 40 6815 6000
Email: investors@sailife.com
Website: www.sailife.com
FAQs
What is the Sai Life Science’s IPO Issue Size?
The Sai Life Science’s IPO issue size is ₹3,042.62 crores.
What is the Sai Life Science’s IPO Price Band?
The price band for Sai Life Science’s IPO is ₹522 to ₹549 per equity share.
What is the Sai Life Science’s IPO Lot Size?
The minimum bid lot for Sai Life Science’s IPO is 27 shares, amounting to ₹14,823.
When is the Sai Life Science’s IPO Allotment Date?
The allotment date for Sai Life Science’s IPO is December 16, 2024.
When is the Sai Life Science’s IPO Listing Date?
Sai Life Science’s IPO is scheduled to list on December 18, 2024, on both BSE and NSE.
Note: Sai Life Science’s IPO price band and date have been officially announced. Sai Life Science’s IPO Grey Market Premium (GMP) will be added to the IPO GMP page as soon as it becomes available.
Stay updated with the latest IPO news on Bapukhabar. Explore key pages like IPO GMP for the latest (Grey Market Premium) GMP on IPO, IPO Listing for recent and upcoming listings on NSE & BSE, IPO Subscription for real-time subscription data, IPO Allotment to check your allotment status, IPO Forms for application details, and SME IPO for updates on Small and Medium Enterprise IPOs.
Follow us on Instagram, Facebook, and Twitter for instant updates and more!
